This site is intended for health professionals only

Editor’s pick

Off-label scrip decisions should assess risks and benefits for asthmatic children
Off-label scrip decisions should assess risks and benefits for asthmatic children
ROLE trial finds ranolazine “well tolerated” in severe chronic stable angina
ROLE trial finds ranolazine “well tolerated” in severe chronic stable angina
Novo Nordisk sets up joint research unit in China
Novo Nordisk sets up joint research unit in China
FDA approves aliskiren for treating hypertension
FDA approves aliskiren for treating hypertension
Review: Human alpha-1-proteinase inhibitor for patients with AAT deficiency
Review: Human alpha-1-proteinase inhibitor for patients with AAT deficiency
Osteoporosis drug begins trials in humans
Osteoporosis drug begins trials in humans
UK wholesalers lose High Court fight on Pfizer supply deal
UK wholesalers lose High Court fight on Pfizer supply deal
GSK launches Russian vaccine informed consent appeal
GSK launches Russian vaccine informed consent appeal
Imatinib ‘has extra anti-cancer properties’
Imatinib ‘has extra anti-cancer properties’
AHA updates NSAID recommendations for heart disease patients
AHA updates NSAID recommendations for heart disease patients
EMEA accepts thalidomide application
EMEA accepts thalidomide application
Are some vitamin supplements linked with higher mortality risk?
Are some vitamin supplements linked with higher mortality risk?
1 … 270 271 272 273 274 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x